Correlation Between Regeneron Pharmaceuticals and Eterna Therapeutics
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Eterna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Eterna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and Eterna Therapeutics, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Eterna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Eterna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Eterna Therapeutics.
Diversification Opportunities for Regeneron Pharmaceuticals and Eterna Therapeutics
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Regeneron and Eterna is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Eterna Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eterna Therapeutics and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Eterna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eterna Therapeutics has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Eterna Therapeutics go up and down completely randomly.
Pair Corralation between Regeneron Pharmaceuticals and Eterna Therapeutics
Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to generate 0.23 times more return on investment than Eterna Therapeutics. However, Regeneron Pharmaceuticals is 4.29 times less risky than Eterna Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Eterna Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 69,616 in Regeneron Pharmaceuticals on December 6, 2024 and sell it today you would earn a total of 228.00 from holding Regeneron Pharmaceuticals or generate 0.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Regeneron Pharmaceuticals vs. Eterna Therapeutics
Performance |
| Timeline |
| Regeneron Pharmaceuticals |
| Eterna Therapeutics |
Regeneron Pharmaceuticals and Eterna Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Regeneron Pharmaceuticals and Eterna Therapeutics
The main advantage of trading using opposite Regeneron Pharmaceuticals and Eterna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Eterna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eterna Therapeutics will offset losses from the drop in Eterna Therapeutics' long position.| Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
| Eterna Therapeutics vs. Arcus Biosciences | Eterna Therapeutics vs. Cullinan Oncology LLC | Eterna Therapeutics vs. Annexon | Eterna Therapeutics vs. Structure Therapeutics American |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |